Object. The goal of this study was to establish whether transplanted cells
derived from fetal human brain can survive in an ischemic lesion.
Methods. Sixteen adult male Mongolian gerbils underwent transient bilateral
common carotid artery occlusion. One week later, cell suspensions prepared
from fetal human brain were injected using stereotactic guidance into the
CA I region of the hippocampus on one side. On the contralateral side injec
tion of the cell suspension medium only was performed. One week after trans
plantation, the animals were perfusion fixed and their brains were processe
d for histological studies as well as expression of neuron and glia-specifi
c antigens. Data from ischemic animals were compared with eight nonischemic
gerbils that served as sham-operated controls. Last, the in vivo data were
correlated with observations made from matching in vitro cultures of the f
etal brain cell suspension.
The in vivo data indicated that transplanted human fetus-derived brain cell
s survived in ischemic lesions of gerbil hippocampus after I week, provided
that the host animal underwent adequate immunosuppression and the transpla
nted cells were not incorporated into the sear caused by the transplantatio
n procedure. Unlike their in vivo counterparts, after I week, most cultured
fetal brain cells expressed either neuron- or astrocyte-specific antigens.
Conclusions. This work demonstrates that xenotransplanted fetal human brain
cells are able to survive in an ischemic lesion in a rodent model. These d
ata might be useful for future neural transplantation studies of treatments
for cerebrovascular ischemia in humans.